TY  - GEN
AU  - Heng,D Y C
AU  - Choueiri,T K
AU  - Rini,B I
AU  - Lee,J
AU  - Yuasa,T
AU  - Pal,S K
AU  - Srinivas,S
AU  - Bjarnason,G A
AU  - Knox,J J
AU  - Mackenzie,M
AU  - Vaishampayan,U N
AU  - Tan,M H
AU  - Rha,S Y
AU  - Donskov,F
AU  - Agarwal,N
AU  - Kollmannsberger,C
AU  - North,S
AU  - Wood,L A
TI  - Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials
SN  - 1569-8041
PY  - 2014///0811
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bevacizumab
KW  - Brain Neoplasms
KW  - drug therapy
KW  - Carcinoma, Renal Cell
KW  - Clinical Trials as Topic
KW  - Disease-Free Survival
KW  - Eligibility Determination
KW  - Humans
KW  - Indazoles
KW  - Indoles
KW  - Kaplan-Meier Estimate
KW  - Karnofsky Performance Status
KW  - Kidney Neoplasms
KW  - Middle Aged
KW  - Molecular Targeted Therapy
KW  - Niacinamide
KW  - Phenylurea Compounds
KW  - Pyrimidines
KW  - Pyrroles
KW  - Sorafenib
KW  - Sulfonamides
KW  - Sunitinib
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1093/annonc/mdt492
ER  -